Author:
Sugiyama Aya,Miwata Kei,Kitahara Yoshihiro,Okimoto Mafumi,Abe Kanon,E Bunthen,Ouoba Serge,Akita Tomoyuki,Tanimine Naoki,Ohdan Hideki,Kubo Tatsuhiko,Nagasawa Akira,Nakanishi Toshio,Takafuta Toshiro,Tanaka Junko
Abstract
AbstractThis cross-sectional study aimed to investigate the post-acute consequences of COVID-19. We conducted a self-administered questionnaire survey on sequelae, psychological distress (K6), impairments in work performance (WFun), and COVID-19–related experiences of stigma and discrimination in two designated COVID-19 hospitals in Hiroshima Prefecture, Japan, between August 2020 and March 2021. The prevalence of sequelae was calculated by age and COVID-19 severity. Factors independently associated with sequelae or psychological distress were identified using logistic regression analysis. Among 127 patients who had recovered from COVID-19, 52.0% had persistent symptoms at a median of 29 days [IQR 23–128] after COVID-19 onset. Among patients with mild COVID-19, 49.5% had sequelae. The most frequent symptoms were olfactory disorders (15.0%), taste disorders (14.2%), and cough (14.2%). Multivariate analysis showed that age was an independent risk factor for sequelae (adjusted odds ratios [AOR] for ≥ 60 years vs. < 40 years 3.63, p = 0.0165). Possible psychological distress was noted in 30.7% (17.9% of males and 45.0% of females). Female sex and the presence of sequelae were independent risk factors for psychological distress. Of all participants, 29.1% had possible impairments in work performance. Experiences of stigma and discrimination were reported by 43.3% of participants. This study revealed the significant impacts of Long COVID on health in local communities. A large-scale, long-term cohort study is desired.
Funder
Hiroshima Prefecture Government–Academia Collaboration Project funding
the Japan Agency for Medical Research and Development
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273. https://doi.org/10.1038/s41586-020-2012-7 (2020).
2. Wiersinga, W. J., Rhodes, A., Cheng, A. C., Peacock, S. J. & Prescott, H. C. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA 324, 782–793. https://doi.org/10.1001/jama.2020.12839 (2020).
3. Ministry of Health, Labour and Welfare, Japan. Discharge and other criteria for patients with new coronavirus infection (variants) [in Japanese]. https://www.mhlw.go.jp/content/000776018.pdf (2021).
4. The Lancet. Facing up to long COVID. The Lancet 396, 1. https://doi.org/10.1016/s0140-6736(20)32662-3 (2020).
5. National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing the long-term effects of COVID-19. https://www.nice.org.uk/guidance/ng188 (2020).
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献